Tower Research Capital (TRC)’s Panagram BBB-B CLO ETF CLOZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-235,706
Closed -$6.05M 5265
2026
Q1
$6.05M Buy
235,706
+34,126
+17% +$895K 0.16% 128
2025
Q4
$5.34M Buy
201,580
+161,051
+397% +$4.28M 0.13% 136
2025
Q3
$1.09M Sell
40,529
-103,295
-72% -$2.77M 0.03% 487
2025
Q2
$3.85M Buy
143,824
+143,334
+29,252% +$3.79M 0.1% 179
2025
Q1
$13K Buy
+490
New +$13.2K ﹤0.01% 3406

Other funds holding CLOZ

Tower Research Capital (TRC)'s CLOZ Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Panagram BBB-B CLO ETF (CLOZ) in Q2 2026, closing a stake of 235,706 shares — an estimated $6.05M sold.

Tower Research Capital (TRC) first reported a position in CLOZ in Q1 2025 and held it in 5 quarters. The position peaked at $6.05M in Q1 2026. 93 funds tracked by Wall St. Rank hold CLOZ as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Panagram BBB-B CLO ETF position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 235,706 Panagram BBB-B CLO ETF shares in Q2 2026, an estimated $6.05M.
  • Tower Research Capital (TRC) first reported a position in Panagram BBB-B CLO ETF in Q1 2025 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s Panagram BBB-B CLO ETF position peaked at $6.05M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Panagram BBB-B CLO ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.